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AN	AUTOMATED	DEVICE	TO	INCREASE	SCREENING	THROUGHPUT	OF	
ZEBRAFISH	LARVAE	By	Fuoad	Saliou-Sulley	Thesis	Advisor:	Dr.	Paul	Millard		An	Abstract	of	the	Thesis	Presented		in	Partial	Fulfillment	of	the		Requirements	for	the		Degree	of	Master	of	Science	(in	Biological	Engineering)	August	2017		 The	use	of	the	zebrafish	as	an	animal	model	alternative	to	mammalian	species	has	spawned	research	advancements	in	several	medical	fields1.	Since	the	zebrafish	shares	a	high	degree	of	sequence	and	functional	homology	with	mammals,	studies	using	this	organism	can	provide	in-depth	insight	into	host	response	to	disease	and	provide	a	platform	for	testing	a	range	of	treatment	options.	The	optical	transparency	of	zebrafish	at	early	stages	of	development	permits	easy	assessment	of	the	effects	of	treatments,	occurrence	of	tumors	or	other	abnormal	growth,	disease	progression,	and	immune	response.		These	characteristics	make	it	ideal	for	studying	human	diseases	such	as	the	Influenza	A	Virus	(IAV).		The	conventional	method	of	IAV	transmission	is	by	aerosol,	and	since	the	zebrafish	does	not	accommodate	this	mode	of	entry,	the	virus	is	injected	into	the	specimen	under	study.	
The	larvae	typically	require	manipulation	during	preparatory	procedures	prior	to	assessment,	a	process	that	can	be	time	consuming	and	stressful	for	the	organism.	In	this	thesis,	I	describe	the	development	of	a	device	designed	to	eliminate	problems	associated	with	manipulating	zebrafish	larvae	by	automatically	conducting	specimen	from	a	reservoir	directly	into	an	entrapment	dock,	where	it	will	be	immobilized	for	injection	and	rapidly	removed	post-injection.	This	will	help	to	reduce	the	handling	time	of	large	sample	sets,	thereby	increasing	the	screening	throughput.	Zebrafish	have	fast	growth	rates4	hence	preparatory	procedures	for	analysis	like	injection	should	be	as	quick	and	efficient	as	possible.	The	device	uses	a	system	to	conduct	48-72	hour	old	zebrafish	through	a	liquid	medium	(egg	water)	using	a	syringe	pump.	The	complete	system	consists	of	three	main	subsystems,	namely	the	pump,	optical	detection	and	entrapment	components.	A	3D	printed	housing	encloses	the	electrical	components	of	the	entire	system.	The	device	works	by	aspirating	individual	fish	through	a	tube	via	a	pressure	gradient	created	with	a	syringe	pump.	Each	cycle	of	the	device	involves	the	following	steps:	(1)	loading,	(2)	sensing,	(3)	trapping,	(4)	injection,	and	(5)	flushing.	During	loading,	a	single	larva	is	extracted	from	the	reservoir	and	conducted	through	a	tube	past	the	optical	detection	subsystem.	At	the	sensing	stage,	the	optical	detection	subsystem	composed	of	a	photodiode	and	a	laser,	senses	transmitted	light	from	the	laser	and	discerns	the	entry	of	larva	from	air	bubbles	and	debris	with	precision.	Upon	larva	recognition,	the	specimen	is	then	conducted	to	the	entrapment	dock	(step	3)	where	it	will	be	immobilized	for	injection	(step	4).	The	final	step	(5)	involves	conducting
the	larva	out	of	the	entrapment	dock	and	subsequently	out	of	entire	system	for	further	analysis.	This	device	will	primarily	serve	zebrafish	researchers	who	intend	to	introduce	vaccines,	pathogens	and	other	experimental	materials	into	many	individual	zebrafish	larvae.					 	
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CHAPTER	1		
LITERATURE	REVIEW	
1.1 								Influenza	Virus	Overview	The	contagious,	acute	respiratory	illness	known	as	the	flu	has	afflicted	humans	for	centuries,	yet	its	precise	origin	remains	a	mystery.	The	working	hypothesis	is	that	wild	aquatic	birds	were	the	primary	reservoir	for	both	bird	and	mammalian	virus	species.		There	is	extensive	evidence	for	the	direct	and	indirect	transmission	of	influenza	from	birds	to	other	species	such	as	pigs	and	horses5.	Influenza	viruses	belong	to	the	Orthomyxoviridae	family	of	RNA	viruses	which	affect	the	upper	and	lower	respiratory	tract.	They	are	spherical	or	filamentous	and	range	in	size	from	80	to	120	nm	in	diameter6,7.	General	symptoms	of	influenza	include 
fever,	malaise,	headache	and	cough8.	The	disease	affects	all	age	groups	but	has	high	prevalence	in	people	under	25	years	and	has	more	drastic	and	life	threatening	effects	in	infants	and	the	elderly9,7,10,11.	Flu	outbreaks	appear	suddenly	and	can	persist	for	a	few	days	to	months,	if	uncontrolled.	The	severity	of	an	outbreak	may	vary	depending	on	the	variant	of	influenza	virus	causing	the	disease.		
1.2			 Influenza	Virus	Variants	There	are	six	genera	within	the	Orthomyxoviridae	virus	family,	and	three,	Influenza	A,	Influenza	B	and	Influenza	C,	contain	viruses	that	can	cause	influenza	in	humans	and	birds,	as	well	as	other	mammals12,13.	These	variants	are	characterized	by	segmented	negative	strand-RNA	genomes	that	are	typically	enclosed	in	a	lipid	envelope.	Subtle	classifications	distinguish	the	three	subfamilies.	Viral	surface	
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proteins	serve	as	unique	identification	markers	for	viruses,	and	typical	surface	proteins	include:	a	hemagglutinin	(HA),	which	agglutinates	erythrocytes	and	plays	a	key	role	in	viral	propagation,	neuraminidase	(NA),	which	is	an	enzyme	essential	for	the	release	of	progeny	virus	particles	from	the	surface	of	an	infected	cell,	and	membrane	(M)	proteins,	which	serve	as	ion	channels.		
1.2.1 Epidemiology-	IAV	The	most	prevalent	form	of	influenza	is	influenza	A,	which	primarily	affects	humans,	other	mammals	and	birds.	Influenza	A	is	a	disease	of	immense	complexity.	Its	occurrence	and	outcome	depend	on	interactions	between	the	virus,	which	is	constantly	changing	its	genetic	and	antigenic	composition,	and	the	immune	system	of	the	host,	which	may	not	be	able	to	respond	adequately	within	a	restricted	time	frame.	The	principal	factor	determining	whether	influenza	outbreaks	occur	is	the	degree	of	complementary	pairing	between	the	surface	antigens	(HA	and	NA)	of	the	virus	and	the	antibodies	against	them,	which	are	in	the	current	population7.	This	class	of	viruses	is	the	most	lethal	of	the	three	(Influenza	A,	Influenza	B	and	Influenza	C),	with	the	ability	to	cause	severe	diseases	on	the	pandemic	scale.	Pandemics	of	influenza	A	have	occurred	about	three	times	per	century	since	1700	and	were	manifested	by	global	spread	of	the	disease,	typically	with	high	morbidity	and	mortality14.	The	most	extreme	pandemic	recorded	in	the	20th	century	was	the	Spanish	influenza,	prevalent	between	1918	and	1919,	with	a	death	toll	estimated	to	have	been	between	20	and	40	million	people	across	the	globe7,14,.	Other	recent	notable	pandemics	include	the	2009	avian	flu	(H1N1)	pandemic; this	virus	
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was	a	unique	combination	of	influenza	virus	genes	never	previously	identified	in	either	animals	or	people,	infecting	millions	and	killing	thousands	worldwide15.		For	several	decades,	the	Centers	for	Disease	Control	and	Prevention	(CDC)	has	made	annual	estimates	of	influenza-associated	deaths,	which	have	been	used	in	influenza	research	to	develop	influenza	control	and	prevention	policy.	Out	of	the	5-20%	of	people	that	contract	the	flu	in	the	United	States	each	year,	the	CDC	estimates	over	20,000	laboratory-confirmed	hospitalizations	annually,	due	to	IAV	and	other	related	complications16,17.	In	addition,	the	economy	is	burdened	by	about	87	billion	USD	due	to	IAV	related	issues,	ranging	from	medical	expenses,	paid	work	absences,	losses	in	productivity,	decline	in	retail	spending,	and	even	tourism18.		
1.2.2 IAV	Transmission	and	Viral	Propagation	The	flu	is	highly	contagious	and	infected	people	can	spread	it	via	aerosol	to	others	up	to	about	6	feet	away.	The	virus	spreads	mainly	through	tiny	aerosol	droplets	produced	when	infected	individuals	cough,	sneeze	or,	occasionally,	just	talk.	The	aerosol	droplets	containing	the	virus	enter	the	mouth,	nose	or	respiratory	tract	of	people	within	proximity.	In	addition,	the	virus	can	be	contracted	when	people	come	into	direct	contact	with	surfaces	and	objects	contaminated	with	the	virus	and	then	later	touch	their	mouth,	nose,	or	eyes.	Contaminated	surfaces	may	include	door	handles,	table	surfaces,	banknotes,	and	electronic	input	devices	like	keyboards.	Research	has	proven	that	IAV	can	survive	on	such	surfaces	for	up	to	eight	hours19,20,21.	The	flu	can	be	contagious	even	before	symptoms	become	apparent.		Most	adults	can	infect	others	beginning	one	day	before	their	symptoms	of	
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the	disease	are	displayed	and	can	remain	contagious	for	up	to	one	week	after	becoming	sick19.	Young	children	with	weakened	immune	systems,	however,	can	be	contagious	well	past	a	week.		Upon	infection,	the	virus	replicates	in	the	upper	and	lower	respiratory	tract,	reaching	its	peak	at	2-3	days	after	infection.	Symptoms	of	the	disease	start	to	become	apparent	at	this	stage19.	The	virus	induces	pathologic	changes	throughout	the	respiratory	tract,	with	the	most	significant	pathology	occurring	in	the	lower	respiratory	tract.	Bronchoscopies	of	persons	with	the	flu	show	a	diffuse	involvement	of	the	trachea,	larynx	and	the	bronchi,	with	acute	mucosal	inflammation	and	edema.	The	virus	has	an	affinity	for	cells	in	the	epithelial	lining	of	the	respiratory	mucosa.	For	viral	propagation	to	initiate,	infection	of	these	cells	must	occur.	Infection	begins	by	virus	binding	to	the	surface	of	the	host	cell,	followed	by	the	fusion	of	viral	and	host	cell	membranes.		The	attachment	and	fusion	is	mediated	by	virus	hemagglutinin	glycoprotein	(HA)	interacting	and	binding	to	sialic	acid	cell	receptors.	Binding	to	sialic	acid	occurs	via	a	shallow	cavity	near	the	distal	tip	of	the	HA	glycoprotein.	Subsequently,	influenza	virus	enters	the	cell	by	receptor-mediated	endocytosis22.	Since	the	virus	has	no	need	for	DNA	coding,	transcription	occurs	within	the	nucleus,	followed	by:	replication	of	viral	RNA	and	secondary	transcription,	translation	of	viral	RNA	to	produce	viral	proteins,	then	culminating	with	the	assembly	of	viral	structural	components	and	the	release	of	progeny	virus	into	the	extracellular	medium.				
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1.2.3 Clinical	Features	of	Infection	In	humans,	influenza	is	characterized	by	the	sudden	onset	of	an	acute	respiratory	illness	accompanied	by	headaches,	chills	and	nonproductive	cough.	This	is	usually	followed	by	muscle	aches,	high	fever,	generalized	weakness	and	loss	of	appetite.	The	fever	usually	declines	by	the	third	day	and	is	gone	after	about	a	week,	but	the	coughing	and	signs	of	weakness	can	persist	for	about	two	more	weeks10.	Due	to	the	virus’	nature	of	compromising	the	immune	system,	the	host	can	be	prone	to	infection	by	other	pathogens	that	can	lead	to	further	complications.	Complications	of	the	flu	can	include	ear	infections,	sinus	infections,	dehydration,	and	worsening	of	chronic	medical	conditions	such	as	congestive	heart	failure	or	diabetes.	More	severe	illnesses	such	as	primary	influenza	pneumonia	can	develop,	which	can	be	lethal.		Secondary	bacterial	pneumonia,	a	more	rare	form	of	the	disease,	can	also	occur	if	the	flu	goes	untreated23.	People	over	65	years	of	age,	those	with	heart	conditions,	asthma,	emphysema,	AIDS	or	people	receiving	chemotherapy	are	at	an	increased	risk	of	complications	from	influenza.			
1.3 				Current	IAV	Research	Influenza	A	viruses,	due	to	their	genetic	makeup	and	mode	of	propagation,	are	continuously	changing	in	several	animal	hosts,	including	birds,	pigs,	horses	and	humans24.		As	a	result	of	the	rapid	and	constant	emergence	of	new	viral	strains,	IAV	is	highly	likely	to	cause	human	epidemics.	It	is,	however,	necessary	that	naturally	occurring	IAV	should	be	monitored	and	characterized	to	improve	the	current	understanding	of	the	host	tropism	as	well	as	the	virulence	of	IAV.	There	have	been	
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numerous	research	advancements	in	IAV	research	in	the	past	few	decades,	some	of	which	include,	but	are	not	limited	to:	viral/human	surveillance	and	characterization,	influenza	genome	diversity	of	evolution,	vaccination	technologies,	tissue	pathology	and	influenza	animal	model	manipulation	technologies24,25,26,27,28,29,30.	The	National	Institute	of	Allergy	and	Infectious	Disease	(NIAID)	Influenza	Research	Program	supports	research	to	learn	more	about	the	structure	and	pathogenesis	of	influenza	viruses.	Such	research	has	proven	to	be	invaluable	to	the	development	of	new	vaccines,	therapeutics,	and	diagnostics31.	Current	research	involves	understanding	viral	replication,	the	emergence	of	new	viral	strains	and	the	effect	those	have	on	the	immune	system.	A	major	NIAID	activity	is	the	Influenza	Genome	Sequencing	Project.	This	is	a	joint	effort	to	obtain	complete	genetic	footprints	of	thousands	of	human	and	avian	influenza	strains,	with	the	goal	of	providing	valuable	genomic	knowledge	that	can	be	used	to	create	improved	public	health	countermeasures.	As	of	May	2014,	more	than	16,000	human	and	avian	isolates	have	been	completely	sequenced	and	made	publicly	available32.		 NIAID	also	supports	the	research	community	by	developing	new	animal	models	for	preclinical	evaluation	of	vaccine	and	therapeutic	candidates.	Animal	models	are	useful	tools	that	serve	as	biological	resources	for	microarrays,	clones,	peptides,	and	reagents.		
1.4 				Animal	Models	Animal	models	have	been	pivotal	in	research	for	decades,	leading	to	major	drug	discoveries	and	medical	breakthroughs33,34.	Suitable	models	are	usually	
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selected	based	on	physiological,	anatomical	and	genetic	resemblance	with	humans.	The	unlimited	supply	and	ease	of	manipulation	are	some	of	the	general	advantages	of	animal	models.	Scientific	research	can	sometimes	involve	statistical	analysis	of	test	specimens,	mostly	by	manipulating	only	one	variable	while	keeping	others	constant,	and	then	observing	the	consequences	of	that	change.	An	adequate	number	of	test	specimens	are,	however,	required	to	accomplish	this	task	effectively.	The	relative	ease	of	manipulating	large	sample	sizes	makes	animal	models	invaluable	to	medical	research.		Rodents	are	the	most	common	type	of	mammal	used	in	experimental	studies.	Extensive	research	has	been	conducted	using	rats,	mice,	gerbils,	guinea	pigs,	and	hamsters35,36.	Among	these	rodents,	the	majority	of	genetic	studies,	especially	those	involving	disease,	have	employed	mice	because	their	genomes	are	similar	to	that	of	humans	and	many	unique	strains	have	been	developed.	Other	common	experimental	organisms	include	fruit	flies,	baker's	yeast	and	zebrafish37.		
1.4.1	 Zebrafish	as	An	Influenza	A	Virus	Model	Animal	models	of	influenza	are	essential	to	research	that	focuses	on	gaining	a	better	understanding	of	the	virus	and	its	effect	on	humans.	There	are	currently	various	research	applications	of	animal	models	ranging	from	the	pathogenesis	and	host	response	to	IAV	to	antiviral	drug	screenings	and	pre-clinical	testing	of	antiviral	drugs	and	vaccines.	IAV	animal	models	are	also	used	to	investigate	the	competency	of	vaccines	and	drugs	to	combat	the	virus,	prevent	future	complications	and	commonly,	to	reduce	the	symptoms	of	influenza.	In	selecting	the	models	for	
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research,	a	couple	of	factors	have	to	be	considered.		The	most	important	criterion	is	the	susceptibility	of	the	animal	to	influenza	virus	infection	while	supporting	viral	replication,	and	exhibiting	human	histopathological	and	morphological	symptoms	of	an	influenza	virus	infection38.		Zebrafish	(Danio	rerio)	models	for	infectious	diseases	are	well	established	for	characterization	of	bacterial,	fungal	and	viral	infections	39,40,41.		The	National	Institutes	of	Health	(NIH)	along	with	other	research	bodies	has	approved	the	zebrafish	animal	model	for	use	in	the	advancement	of	biomedical	studies.	Some	of	its	inherent	advantages,	such	as	optical	transparency,	minimal	husbandry,	large	clutch	size	and	fast	reproductive	cycle	make	the	zebrafish	an	ideal	specimen	for	high-throughput	drug	testing.		Another	important	factor	to	consider	is	that	zebrafish	are	propagated	at	the	optimal	incubation	temperature	for	viruses	during	infection	studies.	Zebrafish	can	be	grown	in	a	temperature	range	within	that	of	the	human	respiratory	tract	(from	25	to	33°C).		As	a	result,	the	zebrafish	might	be	well	suited	to	modeling	human	respiratory	viral	infections,	given	the	similarities	between	the	zebrafish	swim	bladder	and	the	human	lung42,43,44,45.	There	have	also	been	recent	studies	of	zebrafish	swim	bladder	infections	with	human	fungal	pathogens.	Furthermore,	zebrafish	at	the	early	stage	of	development	are	highly	amenable	to	genetic	manipulation	and	transgenesis2.			 Among	all	of	the	benefits	of	the	zebrafish	animal	model	system,	one	of	the	most	important	characteristics	that	make	this	system	ideal	for	IAV	research	is	the	zebrafish’s	immune	system.	During	the	onset	of	development,	zebrafish	are	known	to	rely	solely	on	the	innate	immune	response	for	the	first	4	to	6	weeks46,47,48.	
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Hematopoiesis	in	zebrafish	produces	largely	the	same	differentiated	cell	types	as	observed	in	mammals.	Monocytes,	neutrophils,	macrophages	and	eosinophils	have	all	been	described	within	the	zebrafish	myeloid	lineage47.	In	addition,	other	cells	with	mammalian	cytotoxic	properties,	such	as	mast	cells	and	natural	killer	cells,	have	also	been	classified	within	zebrafish49.	The	innate	immune	functions	of	these	cells	provide	an	effective	defense	system	during	the	early	stages	of	development50.	
 The	majority	of	the	research	conducted	using	the	zebrafish	model	involves	fish-specific	viral	pathogens	that	have	the	ability	to	infect	and	cause	disease;	however,	few	human	viruses	have	been	demonstrated	to	infect	the	zebrafish51.	Some	recent	studies	have	proven	the	zebrafish	to	be	susceptible	to	viral	infection	by	mammalian	viruses,	as	characterized	by	Burgos	et	al,	where	the	zebrafish	was	used	as	a	model	of	herpes	simplex	virus	type	1	(HSV-1)	infection	of	the	nervous	system52.		Gabor	et	al,	at	the	University	of	Maine	described	a	zebrafish	model	for	human	influenza	A	Virus	(IAV)	infection	and	showed	that	zebrafish	embryos	are	susceptible	to	infection	with	both	influenza	A	strains	APR8	and	X-31	(Aichi).	Influenza-infected	zebrafish	showed	an	increase	in	viral	burden	and	mortality	over	time.	The	expression	of	innate	antiviral	genes,	the	gross	pathology	and	the	histopathology	in	infected	zebrafish	recapitulate	clinical	symptoms	of	influenza	infections	in	humans2.	The	study	was	conducted	based	on	the	premise	that	an	antiviral	state	similar	to	that	in	humans	was	induced	in	infected	specimens,	leading	to	the	deduction	that	zebrafish	can	be	a	suitable	alternative	to	vertebrate	animal	models	used	for	IAV	studies.	Recombinant	influenza	viruses	carrying	a	GFP	reporter	gene	in	the	NS	segment	(NS1-GFP)	were	used	to	characterize	infection	in	the	zebrafish.	Although	
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attenuated	compared	to	the	wild	type	virus,	it	is	typical	for	these	modified	viral	strains	to	replicate	efficiently53.	To	determine	whether	the	modified	human	isolates	of	IAV	could	cause	disease	in	zebrafish	embryos,	different	strains	of	IAV	[APR8	(H1N1)	and	X-31	(H3N2)]	were	injected	intravenously	into	48	hpf	(hours	post	fertilization)	zebrafish	through	the	Duct	of	Cuvier	to	mimic	viral	infection	in	the	human	blood	stream.		An	inert	phosphate	buffered	saline	solution	was	also	injected	into	a	number	of	zebrafish	embryos	in	a	control	setup2.		Data	from	the	study	demonstrated	that	IAV	replicates	within	zebrafish	and	suggests	that	the	death	of	IAV-infected	zebrafish	is	likely	to	be	caused	by	IAV	infection.	To	investigate	the	effect	of	treatment	on	the	zebrafish	immune	system,	an	antiviral	compound	used	for	the	treatment	of	IAV	in	humans	was	introduced,	which	reduced	the	mortality	of	the	infected	fish	as	well	as	the	virulence	of	IAV.		
1.4.2 Pathological	Phenotype	Observed	in	IAV	Infected	Zebrafish	In	an	effort	to	characterize	the	innate	immune	response	of	zebrafish	to	the	presence	of	either	strain	of	IAV	(APR8 or X-31)	in	the	bloodstream,	infected	embryos	were	monitored	over	time	for	behavioral	and	phenotypic	changes2.	A	controlled	set	of	embryos	were	injected	with	PBS	(phosphate-buffered	saline)	and	monitored	under	identical	conditions.	While	fish	in	the	control	setup	displayed	no	abnormal	behavior	or	signs	of	viremia,	the	IAV-injected	zebrafish	exhibited	symptoms	of	lethargy,	with	signs	of	edema	observed	in	the	pericardium	and	yolk	sac.	Furthermore,	the	edema	worsened	over	time	and	additional	pathological	phenotypes,	including	varying	degrees	of	lordotic	curvature	of	the	spine,	were	
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observed.	Other	observations	included	pigmentation	defects,	cranial	irregularities	and	eye	deformities.	Gabor	et	al	extended	the	investigation	to	further	characterize	the	innate	immune	response	of	zebrafish	to	IAV	infection	by	conducting	pathological	analysis	on	the	cellular	level.	Influenza	virus	typically	replicates	in	the	epithelial	cells	throughout	the	respiratory	tract	of	humans	and,	the	virus	can	be	recovered	from	both	the	upper	and	lower	respiratory	tract	of	individuals	who	have	been	naturally	or	experimentally	infected.	IAV	viremia	in	its	acute	stage	can	be	characterized	by	multifocal	destruction	and	desquamation	of	the	pseudostratified	columnar	epithelium	of	the	trachea	and	bronchi29.		It	is	also	typical	for	the	basal	layer	of	the	epithelium	to	be	the	only	structure	remaining.	Edema	and	congestion	of	the	submucosa	can	also	be	observed.	In	the	case	of	the	zebrafish,	Gabor	et	al.	prepared	tissue	samples	from	IAV	infected	zebrafish	48	after	injection.	Analysis	of	the	tissues	confirmed	the	clinical	symptoms	of	influenza,	including	necrotic	tissues	and	edema.		
1.5	 Systemic	IAV	Infection		 The	vascular	system	allows	the	flow	of	blood	from	the	heart	to	all	parts	of	the	body,	supplying	oxygen	to	the	most	vital	organs	such	as	the	kidneys,	the	brain	and	the	liver.		Since	blood	within	this	system	is	distributed	throughout	the	body	from	the	aorta,	introduction	of	a	blood	borne	pathogen	such	as	IAV	into	the	vasculature	expedites	viral	infection	throughout	the	body.	IAV	is	characterized	by	hemagglutinin	(HA),	an	antigenic	glycoprotein	usually	found	on	their	surfaces.	These	glycoproteins	
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are	responsible	for	binding	the	virus	to	the	cell	that	is	being	infected54.	The	viral	hemagglutinin	proteins	bind	to	sialic	acid	groups	of	cellular	surface	glycoproteins	to	achieve	viral	attachment	and	entry.	The	specificity	of	the	HA-Sialic	binding	complex	is	one	of	the	major	determinants	for	controlling	viral	tropism	and	host	specificity	This	explains	why	some	organisms	are	susceptible	to	certain	disease-causing	pathogens,	while	others	are	not.	Typically,	human	influenza	viruses	have	a	binding	preference	for	α2,6-linked	sialic	acid.	Avian	influenza	virus,	on	the	other	hand,	binds	to	the	α2,3-linked	sialic	acid	of	the	host	bird56.	Besides	the	conventional	viral	infection	mechanism,	the	virus	can	sometimes	travel	to	acidic	endosomes	for	membrane	fusion	via	clathrin	or	caveolin	mediated	endocytosis57.	Alternate	pathways	into	the	cell	by	viruses	have	also	been	studied,	demonstrating	that	influenza	viruses	have	the	ability	to	employ	different	cell	entry	mechanisms	to	achieve	viral	infection.	It	is,	however,	not	known	whether	all	influenza	viruses	have	the	ability	to	use	the	other	various	pathways	with	identical	preferences	56,	58,	59,	60.		Following	the	interaction	between	the	viral	HA	and	the	α2,6-linked	sialic	acid,	endocytosis	of	the	viral	particle	is	triggered.	Figure	1	demonstrates	a	typical	process	of	cell	entry	of	two	different	viruses:	Influenza	and	HIV.		 	
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Schematic	 diagrams	 of	 HIV-1	 and	 influenza	 virus	 fusion	 and	 entry	 processes.	 Major	
conformational	changes	in	the	viral	envelope	glycoproteins	occur	for	fusion	of	both	HIV-1	and	influenza	
virus,	but	the	requirements	for	fusion	differ,	as	do	the	viral	target	types	(not	shown).	For	HIV-1,	gp120	
binds	 sequentially	 to	 its	 primary	 receptor	 CD4	 and,	 after	 an	 initial	 conformational	 change,	 to	 co-
receptors	(chemokine	receptor)	CCR5	or	CXCR4	(not	shown)	(step	1a).	Co-receptor	interaction	triggers	
fusion	of	the	viral	and	cellular	membranes,	initiated	by	the	HIV-1	fusion	peptide	that	is	located	in	gp41	
(step	2a).	Fusion	and	entry	of	the	HIV-1	genomic	RNA	and	accompanying	viral	proteins	into	the	target	
cell	occurs	at	the	cell	surface	at	neutral	pH.	Following	entry,	the	HIV-1	RNA	genomes	are	transcribed	by	
reverse	 transcriptase	 into	DNA	(step	3a)	and	the	HIV-1	pre-integration	complex	 is	 transported	to	 the	
nucleus	for	integration	into	target	cell	genomic	DNA	to	initiate	chronic	infection.	On	different	cell	types	
from	those	affected	by	HIV-1,	influenza	virus	binds	via	haemagglutinin	1	(HA1)	to	terminal	sialic	acids	
present	on	glycoproteins	or	on	glycolipids	(step	1b).	The	virus	is	subsequently	internalized	by	receptor-
mediated	endocytosis	into	a	low	pH	compartment	(endosome),	triggering	conformational	changes	that	
expose	 the	 viral	 fusion	 peptide	 that	 is	 located	 in	 HA2	 (step	 2b).	 Subsequently,	 the	 genomic	
ribonucleoprotein	complex	is	transported	to	the	nucleus	to	initiate	transcription	and	replication	of	the	
viral	genome	(step	3b).	
	
Figure	1:	Process	of	influenza	virus	infection.	
Karlsson	et	al.	Schematic	diagrams	of	HIV-1	and	influenza	virus	fusion	and	entry	
processes.	Diagram.	The	challenges	of	eliciting	neutralizing	antibodies	to	HIV-1	and	to	
influenza	virus.	Fall	2008;	6(2):	148.	Available	from	Nature	Reviews	Microbiology.	
Accessed	May	6	2017.	
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Influenza	virus	binds	to	terminal	sialic	acids	present	on	glycoproteins	or	glycolipids	via	HA1.	The	virus	is	subsequently	internalized	by	receptor-mediated	endocytosis	into	an	endosome.	This	initiates	conformational	changes	that	expose	the	viral	fusion	peptide	located	on	HA2.	The	entire	viral	protein	complex	is	then	transported	to	the	nucleus,	where	transcription	and	replication	of	the	viral	genome	will	occur	Replication	and	translation	of	the	viral	RNA	produces	new	viral	macromolecules,	which	are	ultimately	assembled	into	complete	viral	particles	for	release	and	infection	of	new	cells62.			
1.5.1		 α	2,6-linked	Sialic	Acids	in	Zebrafish	The	presence	of	compatible	sialic	acid	modifications	on	host	glycolipids	or	glycoproteins	is	one	of	the	main	determinants	of	viral	infection	in	most	animal	species.	The	presence	of	α	2,6-linked	sialic	acid	in	the	zebrafish	makes	this	a	valuable	model	system	for	the	study	of	the	influenza	A	virus.	In	spite	of	this,	there	are	no	known	reported	naturally	occurring	viral	infections	of	the	zebrafish63.	In	an	effort	to	determine	whether	zebrafish	embryos	could	serve	as	a	host	for	infection	with	mammalian/human	isolates	of	IAV,	Gabor	conducted	a	study	to	analyze	the	sialic	acid	linkage	types	present	on	zebrafish	glycoproteins	or	glycolipids2.	Analysis	using	High	Performance	Anion	Exchange	Chromatography	with	Pulsed	Amperometric	Detection	(HPAEC-PAD)	demonstrated	that	α	2,6-linked	sialic	acids	were	present	in	zebrafish	embryos	two	days	after	fertilization.	There	were,	however,	no	α	2,3-linked	sialic	acids	detected	in	the	two	day-old	embryos2.	There	
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are	a	number	of	chemical	variants	of	sialic	acids,	and	influenza	strains	vary	in	their	affinity	for	them.	Terminally	linked	sialic	acids	can	occur	in	α-2,3,	α-2,6,	or	α-2,8	linkages.	Even	though	the	study	was	not	intended	to	identify	α	2,8-linked	sialic	acids,	others	have	previously	demonstrated	that	zebrafish	have	the	ability	to	synthesize	a	variety	of	sialylated	glycoconjugates	during	the	onset	of	their	development	64,65,66.	These	unique	characteristics	of	the	zebrafish	model	system	make	it	an	attractive	candidate	for	studying	infectious	viral	diseases.	With	further	studies	into	sialylated	glycoconjugates	present	at	various	stages	of	development	of	the	zebrafish,	additional	human	viral	diseases	can	further	be	characterized.	Some	of	the	known	human	viral	pathogens	that	have	an	affinity	for	α	2,6-linked	sialic	acids	include	certain	members	of	the	following	virus	families:	coronaviridae,	paramyxoviridae,	caliciviridae,	picornaviridae,	reoviridae,	polyomaviridae,	adenoviridae	and	parvoviridae.	Most	of	these	groups	contain	major	pathogens	for	humans	that	affect	all	parts	of	the	body,	ranging	from	small	organs	like	the	salivary	gland	(in	the	case	of	mumps)	to	cellular	networks	as	intricate	as	the	immune	system2,67,68.		Avian	influenza	virus	strains	have	the	tendency	to	bind	to	sialic	acids	attached	to	galactose	via	an	α	2,3-linkage,	which	is	the	major	sialic	acid	on	epithelial	cells	of	the	duck	gut. Ciliated	epithelial	cells	in	the	human	trachea	lack α	2,3	linked	sialic	acids,	suggesting	that	the	lack	of	a	suitable	receptor	accounts	for	the	inefficient	replication	of	certain	human	viruses	in	duck	intestine	and	of	certain	avian	viruses	in	humans	55,69.			
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1.6			 Zebrafish	Antiviral	Defenses	Although	the	zebrafish	animal	model	has	been	proven	effective	for	testing	medical	treatments	and	virological	assays,	it	can	serve	as	an	ideal	tool	for	understanding	host	biological	responses	after	viral	infections,	particularly	the	Influenza	A	virus.	A	clear	and	thorough	understanding	of	a	host’s	immunity	(both	innate	and	adaptive)	can	provide	insight	into	new	treatments	and	effective	therapies.	The	zebrafish,	like	many	organisms	possesses	innate	and	adaptive	immunity,	however	the	zebrafish	relies	solely	on	its	innate	immune	response	system	for	the	fist	4-6	weeks	of	development2.	Within	this	period	of	growth,	zebrafish	develop	from	the	embryo	to	the	larvae	stage.	This	temporal	separation	of	innate	and	adaptive	immunity	in	zebrafish	allows	for	the	study	of	the	innate	immune	response	to	viral	infection	independent	of	adaptive	immunity.	Upon	viral	attack,	one	of	the	primary	processes	initiated	is	the	induction	of	host	antiviral	state,	which	slows	down	the	rate	of	progression	of	viremia2.	The	major	molecule	responsible	for	the	antiviral	state	is	interferon	(IFN).	Cells	that	are	already	infected	with	a	virus	secrete	interferons	to	prevent	further	virus	exposure	of	healthy	cells.	Response	to	IFN	involves	a	rapid	and	direct	signal	transduction	mechanism	that	quickly	reports	the	presence	of	extracellular	cytokines	to	the	cell	nucleus.	This	preserves	the	specificity	inherent	in	cytokine-receptor	interactions	to	induce	expression	of	a	set	of	genes	via	transcription,	leading	to	encoding	of	important	antiviral	proteins.	Establishment	of	the	resulting	antiviral	state	provides	a	crucial	initial	line	of	defense	against	viral	infection.	Studies	of	IFN-deficient	cells	and	animals	derived	by	gene	targeting	have	demonstrated	the	essential	nature	of	IFN-
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mediated	innate	immunity	70,71,72.		All	blood	cells	in	humans	begin	as	hematopoietic	stem	cells,	and	then	differentiate	into	myeloid	cells	(erythrocytes,	megakaryocytes,	monocytes,	neutrophils,	basophils,	or	eosinophils)	or	lymphoid	cells	(T-lymphocytes	and	B-lymphocytes).	These	immune	cells	typically	perceive	and	respond	to	microbial	stimuli.	Zebrafish	are	largely	similar	to	humans	with	respect	to	cell	differentiation.	They	have	distinct	stages	of	hematopoiesis	that	occur	in	discrete	yet	functionally	analogous	sites.	Zebrafish	myeloid	lineages,	including	monocytes,	macrophages,	neutrophils	and	eosinophils,	have	been	reviewed	and	have	been	characterized	as	similar	to	those	in	humans	47.	The	innate	immune	roles	of	these	cells	offer	an	efficient	defense	mechanism	during	the	onset	of	development.	In	the	case	of	a	viral	infection	such	as	influenza,	the	immune	cells	are	triggered	and	function	accordingly	to	quarantine	the	virus	by	inducing	the	antiviral	state.		Macrophages	and	neutrophils	(large,	mobile	phagocytic	cells)	can	also	be	recruited	to	the	site	of	infection	to	engulf	invading	species.	Macrophages	have	been	known	to	respond	more	quickly	to	infection	than	neutrophils	at	about	30hpf73.	The	relatively	slower	neutrophils	respond	at	about	52hpf	to	complement	activities	of	the	macrophages,	partly	because	the	phagocytic	capability	of	neutrophils	is	relatively	low	compared	to	that	of	macrophages74.	Precursors	of	the	lymphoid	cells	(T-cell	and	B-cells)	begin	the	process	of	rearrangement	and	recombination	of	the	genes	for	immunoglobulin	and	T	cell	receptor	molecules	by	day	4.	This	is	the	onset	of	adaptive	immune	system	development.	The	thymus,	which	is	also	a	lymphoid	organ,	produces	T	cells	and	B	cells	for	the	zebrafish	immune	system,	the	pancreas	has	also	been	reported	to	
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produce	B	cells75,76.	Even	though	the	adaptive	immune	system	begins	forming	early	in	zebrafish	development,	studies	have	shown	that	the	zebrafish	as	incapable	of	mounting	a	full	antibody	response	until	early	adulthood,	which	is	about	4	weeks	post	fertilization.	The	mode	of	pathogenic	defense	up	until	this	point	is	exclusively	dependent	on	the	innate	immune	system77.		In	an	effort	to	understand	the	different	maturation	states	of	the	immune	system	during	zebrafish	development,	S.H.	Lam	et	al	investigated	the	expression	of	six	immune-related	genes	of	the	zebrafish	namely:	Ikaros,	that	encodes	a	transcription	factor	which	is	used	as	an	early	lymphoid	marker;	Rag-1	(Recombination	activating	gene-1),	which	encodes	a	protein	involved	in	genomic	rearrangement	of	the	T-cell	receptor,	immunoglobulin	loci,	and	is	a	suitable	marker	for	maturing	lymphocytes;	T-cell	Receptor	Alpha	Constant	region	genes	(TCRAC)	which	encode	portions	of	the	antigen	receptors	of	mature	T-lymphocytes;	three	immunoglobulin	light	chain	constant	region	genes	(IgLC)	which	encode	portions	of	the	antigen	receptors	of	mature	B	lymphocytes.	Although	there	have	been	cloning	and	characterization	studies	on	immune-related	genes	prior	to	this	study78,79,	there	was	very	little	known	about	the	maturation	of	the	zebrafish	immune	system	with	regard	to	its	form	and	function.	By	employing	standard	profiling	techniques	to	assess	gene	expression	(quantitative	real-time	polymerase	chain	reaction,	in	situ	hybridization	(ISH),	immuno-affinity	purification	and	Western	blotting),	Ikaros	was	detected	first,	at	1	dpf.	The	expression	thereafter	increased	gradually	to	more	than	two-fold	between	28	and	42	dpf	before	decreasing	to	less	than	the	initial	1dpf	expression	level	in	adult	fish	(aged	105	dpf).	Rag-1	expression	levels	increased	
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rapidly	(by	10-fold)	between	3	and	17	dpf,	reaching	a	maximum	between	21	and	28	dpf	before	decreasing	gradually.	In	adult	fish	aged	105	dpf	however,	the	expression	level	of	Rag-1	dropped	significantly,	and	was	equivalent	to	the	expression	level	at	3	dpf.	T-cell	receptor	alpha	constant	region	genes	and	mRNAs	of	immunoglobulin	light	chain	constant	region	(IgLC)	isotype-1,	2	and	3	were	detected	at	low	levels	by	3	dpf	and	their	expression	levels	increased	steadily	to	the	adult	range	between	4	and	6	weeks	post-fertilization	(wpf).	Using	tissue-section	ISH,	Rag-1	expression	was	detected	in	head	kidney	by	2	wpf	while	IgLC-1,	2	and	3	were	detected	in	the	head	kidney	and	the	thymus	by	3	wpf	onwards.	Secreted	Ig	was	only	detectable	using	immuno-affinity	purification	and	Western	blotting	by	4	wpf.	A	humoral	response	to	T-independent	antigen	(formalin-killed	Aeromonas	hydrophila)	and	T-dependent	antigen	(human	gamma	globulin)	was	observed	in	zebrafish	that	were	immunized	at	4	and	6	wpf,	respectively,	indicating	a	normal	immune	response.	The	findings	revealed	that	the	zebrafish	immune	system	is	morphologically	and	functionally	mature	by	4–6	wpf77.	
	
	
1.7			 Injection	of	Zebrafish	Embryos		 One	of	the	most	common	techniques	used	to	introduce	materials	into	zebrafish	embryos	and	larvae	is	injection.	Although	invasive,	it	allows	precise	targeting	of	tissues	and	organs.	When	conducted	under	appropriate	conditions,	such	as	mild	sedation,	injections	pose	minimal	risk	to	zebrafish	larvae.	During	injection,	certain	substances	such	as	nucleic	acids,	proteins,	or	drugs	are	introduced	into	the	zebrafish,	usually	at	the	early	stages	of	development80.	Injections	are	typically	
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conducted	with	glass	needles	filled	with	the	material	to	be	delivered.	The	glass	needles	can	be	fabricated	easily	by	carefully	drawing	out	a	heated	capillary	tube	with	the	appropriate	inner	and	outer	diameter81.	The	glass	needles	are	then	held	by	a	micromanipulator	that	controls	and	changes	the	position	of	the	needle	relative	to	the	embryo	with	high	precision.	Pressure	from	compressed	air	is	used	to	release	the	content	into	the	embryo	or	larva.			
	
Figure	2:	A	typical	micromanipulator	for	manual	injection	needle	operation	in	all	
three	axes	(x,	y	and	z).	It	allows	for	coarse	adjustment	readings	with	an	accuracy	of	
100	micrometers.	Warner	Instruments,	Model	MM-33,	Hamden	CT.		Injection	allows	rapid	delivery	of	material	into	the	zebrafish.	After	manipulation	of	embryos	or	larvae	into	a	suitable	array,	an	experienced	researcher	can	inject	several	hundred	embryos	in	one	hour,	although	the	relatively	high	chances	of	error	associated	with	this	technique,	can	negatively	affect	the	consistency	of	injection.	A	detailed	injection	protocol	consisting	of	zebrafish	loading	and	preparation	has	been	characterized82.		
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1.7.1		 Standard	Techniques	Injection	of	zebrafish	has	been	commonplace	for	decades	and	numerous	procedures	have	been	developed	to	inject	almost	every	part	of	the	live	fish,	notably	the	brain	ventricle,	the	kidney,	the	swim	bladder	and	the	Duct	of	Cuvier	(DC).	The	DC	is	a	wide	blood	circulation	valley	on	the	yolk	sac	connecting	the	heart	to	the	trunk	vasculature.	Injection	through	this	duct	allows	quick	and	efficient	systemic	infection	of	zebrafish	and	is	particularly	useful	for	introduction	of	bacteria	into	embryos	between	1	and	3	dpf.	For	these	injections,	the	needle	is	inserted	into	the	starting	point	of	the	duct	of	Cuvier	just	dorsal	to	the	location	where	the	duct	starts	broadening	over	the	yolk	sac.	This	location	is	the	deepest	section	of	the	duct	and	therefore	provides	the	lowest	risk	of	puncturing	the	yolk	sac.	The	injected	material	will	follow	the	blood	flow	through	the	duct	of	Cuvier,	over	the	yolk	sac	toward	the	heart,	and	can	be	monitored	directly	post-injection	by	monitoring	the	expanding	volume	of	the	duct83.	 
 
1.7.2		 Rapid	Prototyping	and	Influence	of	Technology	on	Research	Ranges	of	technological	advancements	have	paved	the	way	for	new	and	innovative	devices	and	techniques	that	help	make	laboratory	work	more	efficient	and	reliable.	The	rate	of	technological	advancement	has	been	high	within	this	past	decade,	which	may	be	attributable	in	part	to	the	increase	in	computational	power	84.	Another	major	influence	on	technological	advancement	is	the	emergence	of	3D	printing	technologies	for	rapid	prototyping,	which	is	poised	to	revolutionize	device	development	in	many	industries,	including	healthcare.	Since	its	initial	use,	additive	
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prototyping	technology	has	advanced	to	use	in	a	wide	range	of	applications	including	tissue	engineering,	dentistry,	construction,	automotive	and	aerospace	
85,84,86.	The	technology	is	already	changing	the	way	objects	are	made,	with	resulting	products	ranging	from	tools	and	toys	to	clothing	and	even	body	parts.	3D	printing	is	part	of	a	process	known	as	additive	manufacturing	where	an	object	is	created	by	adding	material	layer	by	layer,	usually	at	a	fraction	of	the	cost	and	time	of	standard	means	such	as	forging,	molding	and	sculpting.	In	the	medical	world,	physicians	are	testing	biomaterials	for	regenerative	medicine.	Using	medical	imaging	and	3D-modeling	technology,	surgical	teams	can	now	also	use	3D	printers	to	create	temporary	tools	that	are	affixed	to	the	skeletal	structure	of	the	patient	to	provide	a	precise	"blueprint"	for	reshaping	bone	structure	to	perfectly	accommodate	standard-size	implants.	Custom-printed	drilling	guides	permit	screws	to	be	placed	precisely	to	ensure	the	best	fit	with	a	patient's	body87,88.	Within	the	dynamic	branch	of	zebrafish	research,	prototyping	technologies	are	gradually	being	introduced	to	improve	the	speed	and	quality	of	lab	work30,92,97.	These	technologies	may	have	the	potential	to	make	complex	and	tedious	procedures,	such	as	injection	and	imaging	of	chorionated	embryos,	relatively	simple.	The	following	paragraph	highlights	devices	that	implement	rapid	prototyping	techniques	to	make	working	with	zebrafish	more	efficient.		
1.7.3	 Notable	Devices	for	Zebrafish	Injection		 Pardo-Martin	et	al.	at	Massachusetts	Institute	of	Technology	and	Harvard	University	developed	a	high-throughput	platform	for	cellular-resolution	in	vivo	
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pharmaceutical	and	genetic	screens	in	zebrafish	larvae30.	The	automated	system	is	capable	of	sampling	zebrafish	larvae	and	then	positioning	them	for	imaging.	The	system	is	also	capable	of	manipulating	both	superficial	and	deep	organs	(via	femtosecond	laser	microsurgery).	Each	cycle	of	the	system	includes	the	following	steps:	loading,	sensing,	trapping,	injection	and	flushing.	During	loading,	the	system	extracts	larvae	from	a	reservoir	filled	with	distilled	water.	A	high-speed	optical	detection	system	composed	of	a	photodiode	and	two	LEDs	detects	the	entry	of	larvae	into	the	loading	tube.	The	photodiode	senses	transmitted	and	scattered	light	from	the	laser	light	source.	By	monitoring	the	light	signals,	the	system	can	distinguish	a	larva	from	air	bubbles	and	debris	with	99.99%	reliability	(n	=	100).	After	loading	and	detection,	the	larva	moves	into	a	capillary	positioned	within	the	angle	of	view	of	an	optical	imaging	and	manipulation	system.	Using	a	fast	camera	and	an	automated	image-processing	algorithm,	the	larva	is	coarsely	positioned	by	the	syringe	pump	within	focus	of	the	optical	imaging	system.		At	the	end	of	one	complete	cycle,	animals	can	be	dispensed	back	into	either	individual	wells	or	larger	containers	by	executing	the	loading	process	in	reverse.	While	this	device	boasts	of	effortless	zebrafish	manipulation	for	imaging,	it	falls	short	of	addressing	the	tedious	process	of	microinjection:	a	frequent	and	necessary	step	prior	to	imaging.	Design	of	an	entrapment	mechanism	as	part	of	a	sampling	device	to	accommodate	an	injection	needle	would	add	an	important	manipulation	capability.			 Rohde	et	al	at	Massachusetts	Institute	of	Technology	developed	a	high-speed	microfluidic	sorter	with	the	ability	to	isolate	and	immobilize	small	live	animals	in	a	well-defined	geometry	(within	a	chip)	for	screening	phenotypic	features	in	
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physiologically	active	animals.	The	integrated	chip	contains	individually	addressable	chambers	that	can	be	used	for	incubation	and	exposure	of	individual	animals	to	biological	compounds	and	high	resolution	imaging	without	the	need	for	anesthesia.	Besides	its	sorting	and	immobilizing	function,	the	channels	within	the	microfluidic	chip	can	be	combined	in	various	configurations	to	permit	a	multitude	of	complex	functions	such	as	small	animal	incubation	(eg.	C.	elegans),	immobilization	and	independent	subcellular	resolution	imaging89.	This	system	is	versatile	but	shares	a	similar	limitation	with	the	system	made	by	Pardo-Martin30	and	his	team:	it	does	not	address	the	upstream	procedure	of	animal	injection.	Furthermore,	the	high	multifunctional	capabilities	of	this	system	might	make	it	susceptible	to	cross-contamination	during	use.	Both	the	mechanical	and	electrical	complexity	of	the	system	also	raises	durability	concerns.		 Bischel	et	al	at	University	of	Wisconsin-Madison	designed	a	zebrafish	entrapment	device	that	can	be	used	to	quickly	and	repeatedly	position	zebrafish	embryos	in	a	predictable	array	with	the	help	of	a	pipette.	The	Zebrafish	Entrapment	by	Restriction	Array	(ZEBRA)	is	well	suited	for	use	with	automated	microscope	stages,	thereby	reducing	the	amount	of	imaging	time	and	further	increasing	throughput	compared	to	traditional	methods. ZEBRA	was	designed	and	optimized	to	immobilize	3–5	dpf	zebrafish	embryos	in	a	predictable	array	without	the	use	of	agarose.	The	device	consists	of	an	enclosed	channel	with	a	restriction	width	that	is	accessed	through	an	input	and	an	output	port90.	For	normal	function,	ZEBRA	must	be	filled	with	water	(this	process	requires	oxygen-plasma	treatment	to	render	the	inside	of	the	channels	hydrophilic).	After	initial	filling,	a	pipette	can	be	used	to	add	a	
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droplet	of	water	containing	a	selected	zebrafish	embryo	to	the	input	port	of	the	device.	The	main	function	of	the	device	is	governed	by	passive	pumping:	a	phenomenon	by	which	surface	tension	induces	pressure	differences	to	drive	fluid	movement	in	closed	channels91.	As	a	result,	water	is	driven	from	the	smaller	input	port	(with	higher	surface	tension)	to	the	larger	output	port	(with	lower	surface	tension).	The	zebrafish	is	then	trapped	in	place	upon	reaching	the	channel	restriction.	Users	can	choose	whether	to	load	the	zebrafish	into	the	device	headfirst	or	tail-first	depending	on	the	desired	application.	Passive	pumping	works	reproducibly	as	long	as	there	is	a	closed	channel	between	an	inlet	and	an	outlet91.	This	makes	the	device	more	practical	and	portable	since	it	is	not	dependent	on	a	power	source.	Despite	its	inherent	advantages,	the	device	does	not	accommodate	zebrafish	injection.	The	flow	rate	and	aspiration	conditions	within	the	channels	appear	to	be	dependent	on	the	size	of	the	droplet	placed	at	the	inlet	of	the	device.	As	the	droplet	collapses,	the	aspiration	rate	decreases	thus	creating	a	device	constraint	that	can	potentially	limit	the	length	of	the	channel	between	the	inlet	and	the	outlet	ports91.	Although	less	energy-efficient,	employing	active	pumping	in	this	scenario	can	potentially	eliminate	this	constraint	to	permit	longer	channels	that	can	accommodate	zebrafish,	as	well	as	other	animals,	such	as	C.	elegans.		 Westhoff	et	al	at	University	of	Heidelberg	formed	a	piece	of	brass	to	serve	as	a	negative	mold	to	cast	agarose	to	yield	a	series	of	wells	capable	of	holding	zebrafish	for	imaging	and	micromanipulation92.	The	brass	mold	casts	indentations	into	an	agarose	gel	by	inserting	the	tips	of	the	mold	into	unset	agar	solution	and	allowing	the	solution	to	gel.	The	mold	is	removed,	leaving	voids	that	are	contoured	to	hold	
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zebrafish	larvae	for	imaging.	While	this	device	requires	significant	manual	interfacing,	it	minimizes	the	issue	of	having	to	insert	and	orient	specimens	in	an	agar	medium.	Users	simply	pipette	their	specimen	into	the	wells	prior	to	imaging.	Evenly	spaced	wells	allow	screening	of	large	numbers	of	specimens	and	can	be	automated	with	a	translation	stage.	While	the	device	offers	a	simple	way	for	users	to	probe	and	organize	large	quantities	of	specimens,	it	leaves	little	room	for	automation	of	trans-locating	fish	into	the	device.	As	a	result,	more	user	interaction	is	needed	to	move	and	organize	the	specimens.	Automating	this	process	would	allow	for	minimal	user	interaction	between	the	user	and	the	device.			 The	devices	discussed	above	all	demonstrate	innovative	approaches	to	eliminating	common	problems	of	working	with	zebrafish,	such	as	manipulation;	however,	none	of	them	is	applicable	to	the	principal	function	of	zebrafish	injection.	Using	the	zebrafish	as	an	animal	model	for	IAV	studies	involves	systematically	and	reliably	introducing	the	virus	into	individual	larvae	via	injection.	A	device	to	conduct	and	immobilize	zebrafish	specimens	for	injection	will	be	invaluable	to	IAV	studies,	particularly	where	sample	sizes	are	very	large.		This	project	has	been	directed	toward	design	and	fabrication	of	an	automated	device	that	will	help	solve	this	problem.		The	main	goal	of	the	proposed	device	is	to	provide	a	means	for	storing	and	gently	conducting	zebrafish	from	a	reservoir	to	a	chamber	for	immobilization	and	injection.	This	will	minimize	direct	interaction	between	the	user	and	specimen,	with	the	goal	of	reducing	injection/handling	time	in	experiments	and	to	maximize	reliability	and	laboratory	efficiency,	as	well	as	to	minimize	long-term	costs.	
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CHAPTER	2		
	METHODS	
2.1	 Overview	The	device	employs	a	system	to	conduct	48-72	hour	old	zebrafish	through	a	liquid	medium	(egg	water)	using	a	syringe	pump.	The	complete	system	consists	of	three	main	subsystems	namely	the	pump,	optical	detection	and	entrapment	components.	The	device	works	by	aspirating	individual	fish	through	a	tube	via	a	pressure	gradient	created	with	a	syringe	pump.	Each	cycle	of	the	device	involves	the	following	steps:	(1)	loading,	(2)	sensing,	(3)	trapping,	(4)	injection	and	(5)	flushing.	During	loading,	a	single	larva	is	extracted	from	the	reservoir	and	conducted	through	a	tube	past	the	optical	detection	subsystem.	At	the	sensing	stage,	the	optical	detection	subsystem	composed	of	a	photodiode	and	a	laser,	senses	transmitted	light	from	the	laser	and	discerns	the	entry	of	larva	from	air	bubbles	and	debris	with	precision.	Upon	larva	recognition,	the	specimen	is	then	conducted	to	the	entrapment	dock	(step	3)	where	it	will	be	immobilized	for	injection	(step	4).	The	final	step	(5)	involves	conducting	the	larva	out	of	the	entrapment	dock	and	subsequently	out	of	entire	system	for	further	analysis.		The	syringe	pump	is	pre-programmed	and	manipulated	with	LabView,	the	control	software.	This	device	will	primarily	serve	IAV	researchers	who	intend	to	introduce	vaccines,	pathogens	and	other	experimental	materials	into	many	individual	zebrafish	larvae.				
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Figure	3:	Device	schematic	and	design.	The	device	offers	minimal	interaction	and	
seamless	aspiration	of	zebrafish	specimen,	ultimately	trapping	and	immobilizing	it	for	
microinjection	of	biomaterials.									 				
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The	following	sections	describe	in	detail	the	design	and	construction	of	the	device	components.		
2.2	 Pump	Subunit	Components
	 	
Figure	4:	An	image	of	the	input	reservoir.	The	assembled	reservoir	is	shown	in	Figure	
4.1;	Figure	4.2	and	Figure	4.3	show	the	design	renderings	of	the	top	and	bottom	
reservoir	caps,	respectively.			
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The	device	pictured	above	serves	as	the	entry	point	of	the	zebrafish	specimen	into	the	device.	With	a	maximum	internal	volume	of	60mL,	the	reservoir	is	capable	of	accommodating	about	50	individual	48-72	hpf	larvae.	When	filled	with	egg	water	(Figure	4.1),	the	unique	shape	and	design	allows	enough	room	for	the	fish	to	swim	and	eventually	be	removed	by	suction	through	the	outlet	tube	positioned	along	the	wall	of	the	reservoir’s	bottom	cap.	During	testing,	it	was	observed	that	the	zebrafish	larvae	had	the	tendency	to	sink	downward,	toward	the	deepest	part	of	the	bottom	cap.	This	made	it	difficult	for	specimen	to	be	randomly	removed	from	the	reservoir	through	the	tube,	thus	dramatically	reducing	the	larvae	output	rate.	To	remedy	the	problem,	a	bubbler	was	introduced.	A	narrow	hole	was	drilled	through	the	deepest	part	of	the	bottom	cap	to	allow	for	a	silicone	tube	to	be	threaded	through	and	connected	to	the	bubbler.	An	Aqua	Culture	single	outlet	aquarium	air	pump	was	used	as	the	air	source	Figure	5.		It	includes	a	check	valve	that	prevents	the	siphoning	of	reservoir	water	into	the	air	pump	in	the	event	of	a	power	loss.	
	
Figure	5:	Aqua	Culture	single	outlet	aquarium	air	pump.	The	pump	is	originally	an	air	
pump	designed	for	a	5-	to	15-gallon	aquarium.	It	includes	a	check	valve	(blue	valve	
pictured)	that	can	help	prevent	the	siphoning	of	reservoir	water	into	the	air	pump	in	
the	event	of	a	power	loss.	
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Pressure	is	provided	to	the	system	with	a	New	Era	NE-1000X	Bidirectional	Syringe	Pump.	The	pump	supplies	negative	pressure	(withdraw	mode)	for	a	brief	period	to	cause	specimen	to	be	withdrawn	from	the	reservoir	and	into	the	system	where	it	will	be	sensed	by	the	laser	diode/photodiode	photodetection	system.	The	pump	then	switches	to	positive	pressure	(infuse	mode)	to	allow	the	specimen	to	advance	through	the	system.	
	
Figure	6:	New	Era	NE-1000X	bidirectional	programmable	syringe	pump.	With	fully	
programmable	and	stand-alone	capabilities,	the	pump	can	be	programmed	for	up	to	
41	pumping	phases	that	change	pumping	rates,	set	dispensing	volumes,	insert	pauses,	
control	and	respond	to	external	signals.	It	has	a	dispensing	accuracy	of	±	1%. 	
2.3	 Optical	Detection	Subunit	Components		 The	optical	detection	unit	helps	with	the	direction	of	travel	of	specimen	within	the	system	by	sensing	the	presence	of	zebrafish,	which	prompts	the	syringe	pump	to	switch	between	supplying	positive	and	negative	pressure.	The	two	main	elements	used	for	sensing	are:	a	5mm	transparent	cylinder	head	photodiode	(PD)	
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1	
	
1	 2	2	
(LLSO5-A,	Senba	Optical	Electrical	Co.,	Ltd)	and	a	4.5V	650	nm	red	laser	diode	module	(#01444878,	LightInTheBox	Co.,	Ltd).	During	normal	operation,	the	red	laser	beam	is	focused	onto	the	photodiode	and	a	base	(unobstructed)	voltage	reading	is	observed	and	recorded	(voltage	comparator	circuit	yields	a	HIGH	signal).	The	movement	of	specimen	past	the	light	beam	reduces	the	voltage	reading,	resulting	in	the	voltage	comparator	circuit	producing	a	LOW	signal,	indicating	the	presence	of	a	larva	as	depicted	in	the	cartoon	(Figure	7.1).			
	
	
	
	
	
Figure	7:	An	image	of	the	optical	detection	unit	components.	Figure	7.1	depicts	a	
cartoon	that	highlights	a	zebrafish	larva	moving	past	the	red	laser	beam	to	indicate	
the	presence	of	a	specimen;	the	blue	selection	within	Figure	7.2	shows	the	actual	setup	
of	the	detection	system	mounted	on	a	3D	printed	harness.	
	
	
2.4	 Entrapment	Dock	A	critical	component	of	the	injection	system	is	the	entrapment	dock,	a	device	that	immobilizes	the	specimen	for	injection.	The	dock	was	designed	using	SolidEdge	rapid-prototyping	software	and	3D	printed	using	a	transparent	photopolymer	that	
PEEK Tubing	
Photodiode	
Laser	
		 33	
provides	a	suitable	level	of	surface	smoothness.		The	polymer	(VeroClear-RGD810)	is	a	rigid,	nearly	colorless	material	with	dimensional	stability	for	general	purpose,	fine-detail	model	building	and	visual	simulation	of	transparent	thermoplastics.	The	entrapment	dock	dimensions	are	represented	in	Figure	8.				 								
	
	
	
Figure	8:	Image	of	the	entrapment	dock	with	highlighted	channels	and	dimensions	in	
millimeters.	
	 The	channels	within	the	dock	are	designed	to	accommodate	the	shape	of	a	2-day	old	zebrafish	larva.	Beginning	from	one	end	of	the	dock,	the	channel	begins	with	a	1mm	diameter	opening	to	accommodate	the	capillary	tube	from	the	automated	delivery	system.	It	then	narrows	to	a	micro-constriction	that	is	small	enough	to	allow	some	excess	water	to	flow	past	the	specimen	to	the	other	end	of	the	dock	while	simultaneously	trapping	and	immobilizing	the	specimen	for	injection.	An	
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opening	perpendicular	to	the	trapped	specimen	serves	as	an	entry	for	the	injection	needle.		Despite	the	convenience	and	practicality	of	3D	printing,	the	ability	to	fabricate	small,	intricate	designs	such	as	microchannels	can	sometimes	be	limited.	Although	printers	and	techniques	exist	for	micro	fabrication,	the	cost	of	securing	a	high-resolution	printing	unit	is	high,	with	prices	starting	at	20,000	USD.	Less	expensive	units	can	perform	similar	functions	to	the	more	expensive	machines,	but	with	less	precision.	The	lab	in	which	the	entrapment	dock	was	printed	(Innovative	Media	Research	&	Commercialization	Center,	University	of	Maine)	was	equipped	with	an	intermediate	resolution	3D	printer	(Stratasys	Objet30,	SUP	705	support	material),	and	so	several	challenges	influenced	the	final	design	of	the	port.	Most	notable	amongst	these	was	the	problem	of	lodged	support	material	within	the	microchannels.	Most	3D	printers	employ	the	Additive	Manufacturing	(AM)	design	technique	where	successive	layers	of	material	are	formed	under	computer	control	to	create	an	object;	it	is	analogous	to	building	a	brick	wall	layer	by	layer.	If	a	particular	design	is	supposed	to	have	an	enclosed	opening	or	channel,	support	material	is	deposited	into	the	cavities	to	hold	up	the	structure	as	the	rest	of	the	object	is	being	built.		As	a	result	of	this	process,	all	of	the	entrapment	docks	were	filled	with	support	material	and	post-printing	procedures	to	remove	it	proved	futile.	Some	of	the	procedures	used	were:	applying	mild	heat,	using	biodegradable	solvents	and	manual	excavation	of	the	material	using	a	thin	syringe	needle.	These	problems	spawned	the	idea	of	bisecting	the	original	design	of	the	port	horizontally	and	printing	both	pieces	independently,	as	displayed	in	Figure	9.2.	This	exposes	the	
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channels	and	allows	for	easy	removal	of	the	support	material	without	damaging	the	integrity	of	the	channels.	A	supporting	harness	was	later	designed	and	3D	printed	to	rejoin	and	clamp	together	the	pieces	of	entrapment	dock	Figure	9.3.	
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Figure	9:	Images	of	the	entrapment	dock	and	its	supporting	components	designed	
using	Solid	Edge	CAD	software.	The	3D	printed	solid	is	a	transparent	material	
(VeroClear-RGD810)	that	provides	dimensional	stability	and	a	rigid	finish.	Figure	9.1	is	
an	image	of	the	assembled	entrapment	dock;	Figure	9.2	depicts	the	two	split-pieces	of	
the	entrapment	dock;	Figure	9.3	shows	the	rendering	of	the	supporting	harness	that	
clamps	and	keeps	the	split-pieces	in	place;	Figure	9.4	shows	the	rending	of	the	
completely	assembled	device	with	the	entrapment	dock	highlighted	in	green;	Figure	
9.5	is	an	image	of	the	completely	assembled	device.	
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2.4.1		 Biocompatibility	3D	printing	and	photopolymer	composition	have	improved	tremendously	within	the	past	few	years,	and	problems	with	biocompatibility	have	mostly	been	overcome	by	post-processing	the	3D	printed	device	and	optimizing	the	chemistry	of	the	resins	used	to	create	micro-	and	milli-fluidic	platforms.	The	polymer	used	to	print	the	entrapment	dock	(VeroClear-RGD810)	is	dimensionally	stable	and	is	approved	for	medical	applications93.	In	future	pursuits	to	perfect	the	entrapment	dock	and	to	accommodate	different	organisms,	an	advanced	polymer	(MED610,	made	by	Stratasys)	could	be	used.	This	plastic	has	a	wider	biocompatibility	range	and	might	serve	as	a	better	alternative94.	
Macdonald	et.al	at	the	University	of	Glasgow	assessed	the	biocompatibility	of	four	commercially	available	3D	printing	polymers	(VisiJetCrystal	EX200,	Watershed	11122XC,	Fototec	SLA	7150	Clear	and	ABSplus	P-430)	with	zebrafish	and	observed	the	key	developmental	markers	in	the	developing	embryos.	Their	results	showed	that	the	four	photopolymers	were	very	toxic	to	the	embryos,	resulting	in	fatality	in	most	cases95.	These	results	re-emphasize	the	importance	of	using	biocompatible	materials	to	achieve	reliable	results,	especially	when	conducting	experiments	in	which	morphological	changes	are	analyzed.	It	is	becoming	widely	acknowledged	that	more	detailed	biocompatibility	testing	must	be	provided	by	manufacturers	before	3D	printed	objects	are	used	in	different	biosystems96,97.		 		
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2.5		 Specifications	and	Parameters	1. The	48-72	hpf	zebrafish	larvae	can	be	aspirated	up	to	a	maximum	flow	rate	of	330mm3	s-1,	given	tubing	dimensions	of	0.8mm	inner	diameter	x	2.4mm	outer	diameter.	2. The	maximum	speed	the	larvae	can	attain	in	this	tubing	without	deformation	is	656mm	s-1	3. In	this	system,	Re=528	at	20◦C.	4. The	maximum	aspiration	rate	at	the	delivery	tube/capillary	junction	should	be	below	83μL	s-1	to	avoid	damaging	the	larvae.	5. The	inner	diameter	of	the	input	capillary	is	800μm		
2.6	 Electronics	To	automate	movement	of	the	larvae	in	the	present	system,	electronic	sensors	(e.g.	photodiode)	and	actuators	(e.g.	syringe	pump),	were	used	to	control	fish	movement	through	a	LabVIEW	interface.	The	myDAQ	(National	Instruments,	Austin,	TX)	was	used	to	detect	events	and	to	control	devices,	such	as	the	SC5	solenoid	controller	(RW	Automations,	Figure	10)	used	to	control	the	solenoid	valves.	
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Figure	10:		Electronic	Components.	RW	Automation	SC5	Solenoid	Controller	board	
equipped	with	power,	communication,	and	status	LEDs	(Left);	National	Instruments	
myDAQ	(Right)	
	
	 The	myDAQ	from	National	Instruments	(NI)	is	a	Data	Acquisition	(DAQ)	unit	that	interfaces	with	the	graphical	programming	software	package,	LabView,	and	allows	for	simple	external	control	of	connected	devices.	NI	myDAQ	is	a	simple	and	intuitive	DAQ	device	with	analog	inputs,	analog	outputs,	digital	inputs	and	digital	outputs.	The	digital	output	channels	are	used	to	control	the	Transistor-Transistor	Logic	commands	(TTL)	that	trigger	the	solenoid	pinch	valves.	The	myDAQ	was	also	be	used	as	a	power	supply.			 The	RW	Automation	SC5	solenoid	controller	permitted	programmable	control	of	the	solenoid	pinch	valve	depicted	in	Figure	11.	The	board	controls	five	independent	valves	by	utilizing	a	peak-and-hold	algorithm.	This	allows	the	user	to	
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energize	each	solenoid	valve	at	its	full	rated	voltage	for	fast	actuation	and	strong	pull.	The	SC5	then	automatically	reduces	the	average	voltage	applied	to	the	solenoid	to	conserve	power	and	prevent	overheating	of	the	solenoid	in	the	open/on	position.	
		
Figure	11:	Cole-Parmer	two-way	normally	closed	solenoid	pinch	valve.	12	VDC,	1/16"	
ID	x	1/8"	OD	tubing.	The	solenoid	controlled	pinch	valve	clamps	with	a	force	of	15	PSI	
with	a	25	msec	response	time.		When	triggered,	the	solenoid	controller	applies	12V	to	the	solenoid	valves	for	0.5	sec,	then	reduces	the	voltage	to	a	holding	level	of	~4.5V.	This	minimizes	overheating	of	the	solenoid.	The	SC5	controller	is	under	TTL	control	and	opens	or	closes	the	solenoid	pinch	valves	with	high	or	low	voltage	signals	from	the	DIO	
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channels	of	the	myDAQ	controller.	Low	to	high	voltage	TTL	input	transitions	trigger	the	solenoid	valve	opening,	while	high	to	low	TTL	voltage	transitions	turn	off	the	solenoid	voltage	to	disable	the	solenoid	and	close	the	valve	(NC	state).	TTL	inputs	of	the	solenoid	controller	board	are	interfaced	with	DIO	ports	0-4	on	the	myDAQ	and	controlled	by	a	LabView	VI	with	Boolean	controls.	To	enhance	the	clarity	of	data	and	to	permit	higher	data	acquisition	rates	from	the	optical	detection	system,	a	precision	high-speed	voltage	comparator	was	used	(Texas	Instruments	LM	339N)	to	convert	the	photodiode	voltage	output	to	a	TTL	signal.	The	voltage	comparator	functions	by	comparing	the	differential	voltage	between	the	positive	pin	(sporadic	voltage	from	PD)	and	negative	pin	(stable	predetermined	voltage	from	myDAQ),	then	generating	a	TTL	signal	based	on	the	input	differential	polarity	Figure	12.1.	This	circuit	renders	the	system	less	sensitive	to	potential	false	readings	from	the	PD.							
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Figure	12:	Image	of	the	functional	circuit	diagram.	Voltage	comparator	(left);	wiring	
of	comparator	on	a	breadboard	(Right)	
	 The	LM339N	series	IC	consists	of	four	independent	precision	voltage	comparators	with	an	offset	voltage	specification	as	low	as	2	mV	maximum	for	all	four	comparators.	The	comparator	is	devised	to	operate	from	a	single	power	supply	over	a	wide	range	of	voltages	and	to	directly	interface	with	TTL	(Transistor-Transistor	Logic)	and	CMOS	(Complementary	Metal–Oxide–Semiconductor).			
2.6.1		 Control	Maps/Software	Programming		 	 	 	 	Most	of	the	system	is	managed	manually	through	a	virtual	instrument	dashboard	designed	in	LabView,	Figure	13.	The	platform	allows	automation	of	the	solenoid	valves	and	the	syringe	pump	to	aspirate	zebrafish	larvae	into	the	entrapment	dock.	
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Figure	13:	LabVIEW	control	dashboard.	It	controls	the	automation	parameters	such	as	
the	duration	of	injection;	solenoid	on/off	commands	and	syringe	pump	functions	
(pump/withdraw).	
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LabView	Test	Setup	Routine		 The	following	is	the	data	flow	diagram	for	the	LabView	routine,	which	controls	the	coordinated	functions	of	the	syringe	pump,	the	pinch	valves	and	the	optical	detection	system.		
	
Figure	14:	Valve/syringe	pump	control	map		 All	the	solenoid	valves	are	normally	closed.	A	cycle	begins	with	the	opening	of	valve	1	and	valve	3.	The	syringe	pump	starts	withdrawing	at	a	given	flow	rate	until	a	larva	is	picked	up	from	reservoir	1,	conducted	through	the	tube	and	detected	by	the	optical	detection	system.	The	syringe	pump	immediately	stops	withdrawing	and	valve	1	and	valve	3	close.	Next,	valve	2	and	valve	3	open,	followed	by	the	syringe	pump,	in	infuse	mode,	aspirating	the	larva	at	the	set	flow	rate	to	the	entrapment	dock.	Valve	2	closes	to	prevent	backflow.	Injection	takes	place.	Valve	4	
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and	valve	5	open	after	injection.	Syringe	pump	2,	in	infuse	mode,	flushes	the	larva	out	of	the	entire	system.	The	detailed	setup	and	program	commands	are	highlighted	in	the	appendix.				 	
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CHAPTER	3	
EXPERIMENTAL	RESULTS	AND	DISCUSSION	
	
3.1	 Input	Reservoir	Efficacy	Test	To	evaluate	the	specimen	output	rate	of	the	reservoir,	a	system	test	was	conducted.		
3.1.1	 Procedure		 The	reservoir	was	filled	to	capacity	(60mL)	with	egg	water	(60µg/mL)	at	room	temperature	(21°C),	Figure	4.1.	The	bubbler	was	then	turned	on	to	prevent	settling,	thereby	increasing	the	likelihood	of	larva	uptake	into	the	system.	50	individual	zebrafish	larvae	were	then	introduced	into	the	reservoir.	The	zebrafish	were	anesthetized	with	a	200µg/mL	solution	of	tricaine	before	use.	With	the	larvae	floating	freely	within	the	reservoir,	the	aspiration	tube	was	lowered	into	the	chamber	and	the	syringe	pump	was	set	to	withdraw	mode	at	the	following	flow	rates	for	60	seconds:	10mL/min,	8mL/min,	6mL/min	and	4mL/min.	The	number	of	larvae	aspirated	from	the	reservoir	was	then	recorded	and	the	entire	procedure	was	repeated	10	times,	consecutively.		
3.1.2	 Results			 For	the	entrapment	system	to	be	more	efficient	than	the	traditional	injection	method,	the	reservoir	should	expel	the	larvae	from	the	system	at	a	base	rate	of	3	fish	per	minute.	The	test	of	the	reservoir	at	the	highest	flow	rate	(10mL/min)	generated	an	average	output	of	about	6	larvae	per	minute	Figure	15.	This	translates	to	1	larva	
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output	every	10	seconds,	which	is	a	relatively	shorter	duration	than	the	remaining	time	it	takes	a	larva	to	complete	the	rest	of	the	cycle.	This	implies	that	the	reservoir	must	have	an	output	rate	high	enough	to	support	the	entire	system.	In	spite	of	the	high	output	rate,	only	one	larva	can	be	processed	by	the	system	for	any	given	cycle.	The	high	output	rate	of	the	reservoir	suggests	that	it	has	the	capacity	to	feed	multiple	entrapment	systems	simultaneously.				 	
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Figure	15:	A	bar	graph	depicting	the	number	of	zebrafish	larvae	collected	after	60	sec	
at	different	flow	rates.	
	
	
3.2		 Optical	Detection	Unit	Efficacy	Test	To	evaluate	the	sensitivity	of	the	optical	detection	unit,	a	system	test	was	conducted	routinely.		
3.2.1	 Procedure	First,	the	650nm	laser	module	was	powered	on,	with	majority	of	the	light	beam	centered	on	the	photodiode	(PD).	At	this	point	the	LabView	software,	registered	a	basal	high	TTL	signal	(1,TRUE).	Ten	individual	zebrafish	larvae	(~48hpf)	were	then	fed	through	the	tube,	past	the	laser/PD,	at	10	mL/min.	The	
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decrease	in	light	detected	by	the	PD	resulted	in	a	low	TTL	signal		(0,FALSE)	from	the	comparator	as	the	larva	passed	between	the	laser	and	the	photodiode	and	was	monitored	by	the	control	software.		
3.2.2	 Results	The	results	from	sensor	tests	proved	that	the	light	detection	system	effectively	detected	larvae.	The	waveform	graph,	Figure	16,	displays	10	individual	peaks	that	correspond	to	the	10-zebrafish	specimens	used	in	this	test.	The	initial	voltage	reading	(without	a	comparator	circuit)	from	7-14	seconds	indicates	the	observed	voltage	before	water	or	zebrafish	larvae	were	introduced	into	the	tube.	The	background	noise	apparent	in	several	positions	on	the	chart	(ex.	14-25	seconds)	can	be	attributed	to	air	bubbles.	The	control	software	traces	the	recorded	voltage	readings	that	registered	below	the	basal	reading	(tube+water+specimen),	thus	allowing	us	to	discern	background	noise	from	useful	data.		
		 50	
1	 2	3	4	 10	9	5	 8	6	7	
Figure	16:	A	waveform	chart	of	the	photodiode	voltage	spikes	with	respect	to	time.	The	
base	reading	from	the	PD	is	1V.	The	rest	of	the	labeled	peaks	registering	sub-basal	
voltages	indicate	the	presence	of	a	zebrafish	specimen.		The	comparator	circuit	was	
not	used	to	condition	these	raw	voltage	signals.		
3.3		 Entrapment	Dock	Tests	The	entrapment	dock	is	the	main	part	of	the	system	with	the	core	function	of	immobilizing	48-72hpf	zebrafish	to	allow	tail	injection.	A	series	of	test	trials	were	conducted	to	assess	its	ability	to	entrap	and	immobilize	48-72hpf	zebrafish.		
3.3.1	 Procedure	To	test	its	ability	to	accomplish	trapping,	individual	72hpf	zebrafish	were	introduced	into	the	dock	via	the	inlet	channel	and	subsequently	flushed	out.	For	every	trial	that	was	conducted	(n=100),	the	larva	was	successfully	immobilized	regardless	of	orientation	(head/tail	entry)	as	illustrated	in	Figure	17.	
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Figure	17:	Image	of	the	entrapment	dock	illustrating	the	immobilized	zebrafish	larvae	
in	the	two	possible	orientations.	Head-on	arrival	(left	image)	and	tail	arrival	(right	
image)	
	
	
3.4	 Average	Duration	of	Screening	Steps	(1	Cycle)	The	overall	duration	for	one	cycle	through	the	system	was	determined	in	this	test.	
	
3.4.1	 Procedure		 By	timing	each	automated	stage	of	the	processes	(loading,	trapping,	injection	and	flushing)	within	one	cycle,	the	average	cycle	time	was	calculated.	Since	the	flow	rate	is	varied	at	certain	stages	within	a	given	cycle,	timing	each	step	provides	a	more	
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accurate	projection	of	the	overall	duration	of	one	cycle.	
Table	1:	Average	duration	of	screening	steps	from	the	reservoir	to	the	light	detector	at	
different	flow	rates.	(0.08cm	inner	diameter	and	88cm	length)	
	
Table	2:	Calculated	duration	of	screening	steps	from	the	photo-detector	to	the	
entrapment	dock	at	different	flow	rates.	(0.08cm	inner	diameter	and	80cm	length)	
	
Table	3:	Average	time	required	for	injection		
	
Step	 5mL/min	 4mL/min	 3mL/min	 2mL/min	Entrapment	Dock	→	Exit	 4	 5	 6	 9	
Table	4:	Calculated	duration	of	screening	steps	from	the	entrapment	dock	to	the	exit	
(of	the	entire	system)	at	different	flow	rates.	(0.08cm	inner	diameter	and	62cm	length)	
	
	
	
	
	
	
	
	
Step	 Flow	Rate	(mL/min)	 Time	(sec)	Reservoir	→	PD	 10mL/min	 9±6.5	Reservoir	→	PD	 8.0mL/min	 10±10.4	Reservoir	→	PD	 6.0mL/min	 13±19.5	Reservoir	→	PD	 4.0mL/min	 16±15.3	
Step	 Flow	Rate	(mL/min)	 Time	(sec)	PD	→	Entrapment	Dock	 2mL/min	 12	PD	→	Entrapment	Dock	 1.75mL/min	 14	PD	→	Entrapment	Dock	 1.50mL/min	 16	PD	→	Entrapment	Dock	 1.25mL/min	 19	
Step	 Time	(sec)	Injection	procedure	 User	dependent:	10±3	
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3.5	 Quantitative	Assessment	of	Animal	Health	The	condition	of	each	individual	zebrafish	was	assessed	after	it	passed	through	the	system.	This	assessment	was	based	on	both	functional	and	morphological	criteria.	At	all	flow	rates	(2mL/min,	1.75mL/min,	1.5mL/min,	1.2mL/min),	heartbeat,	touch-response,	structural	integrity	of	the	yolk	sac	and	melanocytes,	were	evaluated	and	compared	to	a	control	sample.	The	larvae	in	the	control	setup	(same	age)	were	aspirated	in	an	unobstructed	tube	spanning	the	length	of	travel	encountered	by	larvae	in	the	experimental	setup.			
3.5.1		 Procedure		 The	zebrafish	from	the	tests	described	in	section	3.4	were	collected	and	viewed	under	a	microscope	to	evaluate	the	following	parameters:	survival	(heartbeat)	and	morphology	(structural	integrity	of	the	yolk	sac	and	melanocytes).	The	following	data	were	recorded	in	Figure	18.		
3.5.2	 Results		 At	all	of	the	flow	rates	used,	100%	of	the	larvae	survived	(n=100)	for	at	least.	Tearing	of	the	yolk	sac	was	never	observed.	At	the	highest	initial	flow	rate	of	2mL/min,	48%	of	the	larvae	exhibited	morphological	abnormalities,	specifically	slight	distortion	of	melanocytes	along	the	tail	and	of	the	yolk	extension,	Figure	18.	With	the	slightly	slower	initial	aspiration	rates	of	1.75mL/min,	all	health	criteria	matched	those	of	the	controls.			
		 54	
		
Figure	18:	Comparison	of	morphological	abnormalities	of	experimental	zebrafish,	at	
different	flow	rates,	with	a	control	zebrafish.	The	red	arrows	show	distortions	of	the	
melanocytes	and	the	highlighted	region	shows	distortions	of	the	eye	and	the	yolk.			
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Figure	19:	Quantitative	assessment	of	zebrafish	health	at	different	flow	rates	(n=100)	
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CHAPTER	4	
		
SUMMARY,	CONCLUSIONS	AND	FUTURE	WORK	
4.1 		 Summary	A	device	to	accelerate	experiments	involving	microinjection	of	large	numbers	of	larvae	was	designed	and	fabricated	using	inexpensive	rapid	prototyping	techniques.		Chapter	1	introduces	the	influenza	A	virus	and	describes	important	aspects	of	the	virus,	including	its	genetics,	distribution,	transmission	and	clinical	symptoms	of	the	disease	that	it	causes.	This	chapter	also	places	emphasis	on	current	IAV	research	advancements	and	reviews	the	use	of	animal	models	for	infectious	disease	research.		Chapter	2	describes	the	device	components	separately	and	reviews	prototyping	methods,	modes	of	device	function	and	supporting	control	software.	The	device	specifications	and	parameters	are	also	highlighted	in	this	chapter.	Chapter	3	presents	efficacy	tests	of	the	main	components	of	the	system.		
4.2			 Conclusions			 A	fully	functional	zebrafish	immobilization	device	was	designed,	fabricated,	and	tested.	48-72	hpf	zebrafish	larvae	were	successfully	immobilized	within	a	3D	printed	dock.	The	experimental	test	setup	allowed	manipulation	of	the	volumetric	flow	rate	within	the	tubes,	pressure	from	the	air	compressor	used	to	create	air	bubbles	in	reservoir	1,	voltage	within	the	optical	detection	system	and	the	overall	device	output	frequency.	The	loading	stage	was	improved	with	the	addition	of	the	bubbler	to	reservoir	1.	This	played	a	major	role	in	distributing	larvae	evenly	within	the	chamber	during	operation.	
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	 Automation	of	the	system	enhanced	test	reproducibility	by	reducing	the	chances	for	human	error.	The	optical	detection	system	proved	effective	(see	waveform	chart,	Figure	16.	Individual	larvae	were	successfully	identified	by	the	detection	system	with	100%	precision	(no	false	positives).	The	control	software	traced	the	recorded	voltage	readings	that	registered	below	the	basal	reading;	moreover,	the	comparator	increased	the	data	acquisition	rate	two-fold,	from	62	Hz	to	124	Hz.		 One	of	the	most	challenging	aspects	of	the	project	was	the	fabrication	of	the	immobilization	dock.	The	3D	printer	that	was	used	for	this	project	deposited	support	material	within	the	channels	and	no	method	used	to	remove	the	material	was	successful.	By	developing	the	split	design	technique,	I	eliminated	this	problem	by	exposing	the	channels	for	simplified	post-print	processing.	The	tests	of	the	entrapment	dock	were	successful,	i.e.	after	running	100	cycles	through	the	dock	at	various	flow	rates:	48%	of	larvae	(n=25)	were	immobilized	without	any	deformation	at	2mL/min,	76%	of	larvae	(n=25)	were	immobilized	without	any	deformation	at	1.75mL/min,	100%	of	larvae	(n=25)	were	immobilized	without	any	deformation	at	1.50mL/min,	100%	of	larvae	(n=25)	were	immobilized	without	any	deformation	at	1.25mL/min.		
4.3			 Future	Work	At	this	stage	of	device	development,	adjusting	the	flow	rate	within	the	system	during	certain	parts	of	a	given	cycle	can	alter	the	frequency	of	the	device’s	output.	In	spite	of	the	automation	incorporated	into	the	device,	the	user	must	manually	trigger	
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the	control	program	to	execute	certain	commands	such	as	when	to	inject	the	specimen.	By	adding	a	minimal	number	of	steps	to	the	existing	control	program,	an	automatic	injector	equipped	with	a	translation	stage	could	be	incorporated	into	the	design	to	reduce	the	need	for	manual	input.	Furthermore,	a	recovery	system	could	easily	integrated	toward	the	end	of	the	device	to	receive	the	injected	larvae	after	ejection	from	the	system.	Ultimately,	the	device	will	provide	a	seamless	user	interface	that	requires	minimal	user	intervention.	By	depositing	a	known	number	of	zebrafish	larvae	into	the	input	reservoir,	and	inputting	the	dosage	of	the	compound	or	chemical	under	study,	the	device	will	be	able	to	inject	and	dispense	larvae	for	analysis.	Microsystems	designed	for	cell-based	studies	or	applications	such	as	this	one	require	fluid	handling.	Flow	within	these	systems	inevitably	generates	fluid	shear	stress	that	may	adversely	affect	the	health	of	the	organisms	under	study.	Simple	assays	of	specimen	viability	and	morphology	were	used	in	this	project	to	detect	any	gross	disturbances	to	larval	anatomy	and	physiology.	However,	it	will	be	beneficial	to	specifically	evaluate	physiological	implications	of	fluid	shear	stress	within	the	tubes	and	the	entrapment	dock.	Varma	et	al.	at	Massachusetts	Institute	of	Technology	explored	a	useful	technique	that	can	assist	us	with	understanding	the	fluid	dynamics	within	this	device.	It	involves	using	a	genetically	encoded	cell	sensor	that	fluoresces	in	a	quantitative	fashion	upon	encountering	fluid	shear	stress	(FSS)98.	Varma	et	al.	chose	a	widely	used	cell	line	(NIH3T3s)	and	created	a	transcriptional	cell-sensor	that	fluoresces	when	transcription	of	a	relevant	FSS-induced	protein	is	initiated.	The	sensor	pathway	specificity	and	functionality	were	
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verified	by	noting	induced	fluorescence	in	response	to	chemical	induction	of	the	FSS	pathway,	seen	both	through	microscopy	and	flow	cytometry.	In	addition,	these	novel	cell	sensors	can	be	induced	with	a	range	of	FSS	intensities	and	durations,	with	a	limit	of	detection	of	2	dynes/cm2	when	applied	for	30	minutes,	making	it	more	versatile	in	simulating	several	microfluidic	flow	conditions.	Undertaking	the	improvements	discussed	above	will	enable	for	a	more	seamless	operation	of	this	device	and	possibly	pave	the	way	for	subsequent	engineering	systems	with	wide	applications	in	the	microsystems	community.																
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APPENDIX	A	
ZEBRAFISH	HUSBANDRY	Zebrafish	were	housed	at	the	University	of	Maine	Zebrafish	Facility	in	recirculating	systems	where	the	water	temperature	was	maintained	at	28°C	with	a	total	system	flow	rate	of	150	liters/min.	Zebrafish	were	maintained	in	accordance	with	the	Institutional	Animal	Care	and	Use	Committee	standards	of	the	University	of	Maine.	Fertilized	zebrafish	eggs	are	collected	according	to	methods	proposed	by	Phennecie	at	the	University	of	Maine	Zebrafish	Facility99.	Collected	eggs	are	raised	for	24	hours	at	28.0	̊C	in	100mm-diameter	petri	dishes	half	full	of	egg	water,	60µg/L	Instant	Ocean	Salts	in	purified	reverse	osmosis	water.	No	more	than	100	eggs	were	raised	in	one	100mm-diameter	petri	dish	at	a	time.		At	24	hours	post	fertilization,	egg	water	is	replaced	in	each	petri	dish.	Chorions	are	removed	from	the	embryos	by	hand	and	discarded	as	biological	waste.	Live	embryos	are	stored	at	28.0	̊C	until	the	following	day.		At	48hpf,	embryos	are	motile.	Egg	water	is	replaced	in	each	petri	dish	and	dead	embryos	are	removed	from	the	container.	Embryos	are	stored	at	28.0	̊C	overnight.		At	72hpf,	specimens	are	considered	larvae.	Zebrafish	egg	water	is	replaced	and	specimens	are	used	as	needed	in	further	laboratory	procedures.				 Zebrafish	were	euthanized	in	a	600µg/L	concentrated	stock	of	Tricane	for	30min	and	fixed	to	minimize	the	amount	of	larvae	needed	for	repeated	testing.	Fish	are	removed	from	anesthetic	and	placed	in	fixative	solution	of	1.5%	gluteraldehyde,	0.5%	para-formaldehyde,	50mM	PBS	(phosphate	buffered	saline)	for	long	term	storage100.	Larvae	were	fixed	for	at	least	12	hours	prior	to	use.	For	flow	testing,	
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chemically	fixed	fish	were	removed	from	fixative	solution	and	placed	in	egg	water	with	no	more	than	0.25%	gelatin	to	minimize	larval	adhesion	to	tubing.		For	procedures	involving	live	specimens,	larvae	are	anaesthetized	in	a	200µg/mL	solution	of	tricane	with	no	more	than	0.25%	gelatin	added	to	minimize	specimen	adhesion	to	tubing.	Fish	were	aspirated	through	the	device	in	the	anesthetic	gelatin	solution.		
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APPENDIX	B		
VALVE/SYRINGE	PUMP	CONTROL	MAP	SETUP:	MyDAQ	DIO	channels	(0-5)	
• Input	–	laser	detector	(detected	fish=1,	nothing	detected=0)	
• Output	–	valve	1	(open=1,	close=0)	
• Output	–	valve	2	(open=1,	close=0)	
• Output	–	valve	3	(open=1,	close=0)	
• Output	–	valve	4	(open=1,	close=0)	
• Output	–	valve	5	(open=1,	close=0)	
• Output	–	syringe	pump	direction	(inject=1,	withdraw=0)	
• Output	–	syringe	pump	start/stop	(start=1,	stop=0)		Program	Commands:	
• All	valves	closed,	pump	stopped	
• Set	pump	to	withdraw	mode	
• Close	valve	2,	Close	valve	4,	Close	valve	5(should	be	closed	already)	
• Open	valve	1	and	valve	3	
• Start	pump	1	
• Monitor	detector	
	 If	positive	detect	→	stop	pump,	close	valve	1,	close	valve	3,	open	valve	2,	open	valve	3	set	pump	to	inject,	start	pump	
• Pump	injects.	Duration:	(input	value)	seconds	→	stop	pump,	valve	2	close	
		 74	
• Inject.	Duration:	(input	value)	seconds	
• Open	valve	4,	open	valve	5	
• 	Start	pump	2	(infuse)	
• Wait	for	fish	to	flush	out.	Duration:	(input	value)	seconds	
• Stop	pump	
• Close	valve	5	
• Go	to	Step	1		
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APPENDIX	C		
MATERIALS	LIST	Pump	System	Materials:	
	 Tygon	Micro	Bore	Tubing,	Part	#:	TGY-030.	Component	Supply	Co.	
	 Silicone	Tubing,	Part	#:	SCT-063A.	Component	Supply	Co.	
	 BD	60mL	Syringe,	Part	#:	309654.	Becton,	Dickinson	and	Company.	
	 New	Era	NE-1000X	Programmable	Syringe	Pump	
	 2-way	normally	closed	solenoid	pinch	valve,	Part	#	98302.	Cole	Palmer	Instrument	Company,	LLC.	
	 Aqua	Culture	Single	Outlet	Aquarium	Air	Pump,	Part	#	0079285405132		Optical	Detection	Materials	
	 5mm	transparent	cylinder	head	photodiode,	Part	#	LLSO5-A.	Senba	Optical	Electrical	Co.,	Ltd		
	 4.5V	650	nm	red	laser	diode	module,	Part	#	01444878.	LightInTheBox	Co.,	Ltd		
	 PROCELL	1.5V	dry	cell	batteries,	Part	#	PC1500.	Duracell	Inc.		Entrapment	Dock	Materials	
	 Objet30	Rapid	Prototyping	System,	SUP705	Support	Material	(Water	Jet	Removable).	Stratasys	Ltd.	
	 Custom	Stage	Mount	
	 MakerBot	Replicator	Desktop	3D	Printer,	PLA	Filament.	MakerBot	Industries,	LLC.	
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	Electronics	
	 National	Instruments	myDAQ	Unit	
	 SC5	Five-Channel	Solenoid	Controller/Driver.	RW	Automations,	LLC.	
	 SolidEdge	ST7.	Siemens	Product	Lifecycle	Management	Software	Inc.	
	 National	Instruments	LabVIEW	2016.	National	Instruments.		 	
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